iHuman Inc. IH
1.04 USD 0.00 (+0.00%)
Nov 12, 2026, 1:54 PM EST
1.01 Day range 1.01
1.00 52-week range 2.99
- YTD
- -50.71%
- 1 year
- -62.64%
News
benzinga.com iHuman Q2 Adj. EPS $(0.05) Down From $0.08 YoY, Sales $25.553M Down From $27.942M YoY iHuman (NYSE:IH) reported quarterly losses of $(0.05) per share. This is a 162.5 percent decrease over earnings of $0.08 per share from the same period last year. The company reported $25.553 million…
benzinga.com iHuman Q1 Adj. EPS $0.01 Down From $0.07 YoY, Sales $26.456M Down From $28.999M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.01 per share. This is a 85.71 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $26.456 million…
benzinga.com Earnings Scheduled For March 31, 2026 
benzinga.com iHuman Q4 Adj. EPS $0.04 Down From $0.07 YoY, Sales $27.300M Down From $31.878M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.04 per share. This is a 42.86 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $27.300 million…
benzinga.com 12 Communication Services Stocks Moving In Tuesday's Pre-Market Session - benzinga.com Earnings Scheduled For December 29, 2025
benzinga.com iHuman Q3 Adj. EPS $0.06 Down From $0.07 YoY, Sales $28.900M Down From $34.115M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.06 per share. This is a 14.29 percent decrease over earnings of $0.07 per share from the same period last year. The company reported $28.900 million…- benzinga.com 12 Communication Services Stocks Moving In Wednesday's After-Market Session
benzinga.com iHuman's International Push Boosted By Cricket Media Tie-up 
benzinga.com iHuman Q2 Adj. EPS $0.08 Up From $0.06 YoY, Sales $27.942M Down From $29.600M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.08 per share. This is a 33.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $27.942 million…- benzinga.com 12 Communication Services Stocks Moving In Thursday's Pre-Market Session
benzinga.com iHuman Reported Q1 2025 MAUs Of 26.5M Vs 26.4M YoY iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first…- benzinga.com iHuman Q4 Adj $0.07 Down From $0.09 YoY, Sales $31.88M Beat $30.74M Estimate iHuman (NYSE:IH) reported quarterly earnings of $0.07 per share. This is a 22.22 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales…
benzinga.com 12 Communication Services Stocks Moving In Wednesday's Intraday Session - benzinga.com 12 Communication Services Stocks Moving In Thursday's Pre-Market Session
- benzinga.com Tesla, Toyota And 3 Stocks To Watch Heading Into Thursday
benzinga.com iHuman's Q3 MAUs Rose 14.8% YoY To 29.12M Average total MAUs for the quarter were 29.12 million, an increase of 14.8% year-over-year from 25.36 million in the same period last year, primarily due to the effective execution of our user…- benzinga.com iHuman Extends Share Buyback Program By Another 12 Months Through End of 2025 Given its confidence in the Company's business prospects, the board of directors (the "Board") has authorized an extension of the Company's existing share repurchase program, as authorized in…
- benzinga.com 12 Communication Services Stocks Moving In Monday's Intraday Session
benzinga.com iHuman Misses China Stock Rally As Investors Fret Over Stumbling Growth Key Takeaways: iHuman’s revenue and profit both declined in the first quarter as it accelerated a global expansion plan to diversify beyond its softening home market in China The company’s gross…- benzinga.com 12 Communication Services Stocks Moving In Monday's Pre-Market Session
- benzinga.com Earnings Scheduled For February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
- benzinga.com iHuman Q4 Adj. EPADS $0.09 Down From $0.11 YoY, Sales $35.27M Down From $37.80M YoY iHuman (NYSE:IH) reported quarterly adjsuted earnings of $0.09 per share. This is a 18.18 percent decrease over earnings of $0.11 per share from the same period last year. The company reported $35.27…
- benzinga.com Overview Of Value Stocks In The Consumer Defensive Sector
- benzinga.com 5 Value Stocks To Watch In The Consumer Defensive Sector
benzinga.com 5 Value Stocks In The Consumer Defensive Sector - benzinga.com iHuman Average Total MAUs Q3 Were 25.36M, Up By 22.9% YoY Average total MAUs for the quarter were 25.36 million, an increase of 22.9% year-over-year from 20.63 million in the same period last year. The number of paying users was 1.54 million.
- benzinga.com iHuman Q3 EPS $0.14 Up From $0.11 YoY, Sales $35.80M Up From $35.36M YoY iHuman (NYSE:IH) reported quarterly earnings of $0.14 per share. This is a 27.27 percent increase over earnings of $0.11 per share from the same period last year. The company reported $35.80 million…
- benzinga.com Overview Of Value Stocks In The Consumer Defensive Sector
- benzinga.com 5 Value Stocks To Watch In The Consumer Defensive Sector
- benzinga.com A Look Into Consumer Defensive Sector Value Stocks
- benzinga.com Overview Of Value Stocks In The Consumer Defensive Sector
- benzinga.com 5 Value Stocks To Watch In The Consumer Defensive Sector
- benzinga.com 5 Value Stocks In The Consumer Defensive Sector
- benzinga.com 10 Communication Services Stocks Moving In Friday's Intraday Session
- benzinga.com 12 Communication Services Stocks Moving In Monday's Intraday Session
- benzinga.com Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
- benzinga.com Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation.
- benzinga.com Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,…
- benzinga.com 30 Stocks Moving in Tuesday's Pre-Market Session Gainers
- benzinga.com 96 Biggest Movers From Yesterday Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 671 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 115 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday morning, 155 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday morning, 173 companies reached new 52-week lows.
- benzinga.com 12 Communication Services Stocks Moving In Friday's After-Market Session Gainers AMC Networks (NASDAQ:AMCX) stock rose 2.39% to $68.4 during Friday's after-market session. AMC Networks's trading volume hit 443.7K shares by close, accounting for 74.35% of its average…
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's morning session, 92 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's morning session, 88 stocks hit new 52-week lows.
benzinga.com 60 Biggest Movers From Yesterday Gainers Marin Software Incorporated (NASDAQ: MRIN) shares jumped 150.7% to close at $3.76 on Wednesday following a 22% surge on Tuesday.- benzinga.com 58 Stocks Moving In Wednesday's Mid-Day Session Gainers Astrotech Corporation (NASDAQ: ASTC) shares climbed 139.5% to $3.9750 after the company announced partnership with Cleveland Clinic to develop a rapid COVID-19 breath test.